Multiple Sclerosis, Rituximab, Hypogammaglobu...

Dr. Tesha Monteith talks with Dr. Jennifer Robblee about the latest consensus on refractory migraine, its definition, and management strategies, including new guidelines for emergency treatment. Read the related article in Cephalalgia. Read the related article in Headache. Disclo ...  Show more

Dr. Tesha Monteith talks with Dr. Patricia Pozo-Rosich about the latest advancements in headache medicine, focusing on key research findings from 2025. Disclosures can be found at Neurology.org. 

Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0 ...  Show more

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this a ...

This program discusses peripheral nerve diseases, including the anatomy of the central and peripheral nervous systems by Dr. Maggie Waung. Peripheral nerves control sensory, motor and autonomic functions and can regenerate though very slowly. Dr. Michael Wilson discusses difficul ...  Show more

Go online to PeerView.com/BQF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Neurofibromatosis type 1 (NF-1) is a rare autosomal dominant disorder of the nervous system that is associated with significant morbidity, includin ...  Show more